GlassScriptPhysician profile
Aditya Mangla
NPI 1548453285
$74,214.15
in general payments reported to CMS, 2019-2025
38 companies · $4,333 in 2025
The $4,333 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,055 · 2020: $4,937 · 2021: $4,977 · 2022: $9,216 · 2023: $15K · 2024: $28K · 2025: $4,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $19K · Food and Beverage: $14K · Consulting Fee: $7,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,117.88 |
| Food and Beverage | $14,311.38 |
| Consulting Fee | $7,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,835.40 | 2021-2025 | Symplicity G3, Onyx Frontier, Acist Rxi System |
| Inari Medical, INC. | $13,756.05 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $12,316.04 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $4,886.73 | 2022-2025 | Indigo System |
| Abiomed | $4,136.24 | 2019-2024 | Impella |
| Abbott Laboratories | $3,785.68 | 2019-2025 | Dragonfly Opstar, Merlin@Home, Diamondback Coronary |
| Boston Scientific Corporation | $3,773.46 | 2019-2025 | Avvigo Guidance System, Rotapro, General - Therapies |
| Medtronic Vascular, INC. | $3,054.86 | 2019-2020 | |
| Cardiovascular Systems INC. | $2,517.89 | 2019-2022 | |
| Endologix LLC | $1,526.70 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Philips North America LLC | $1,453.42 | 2019-2023 | |
| Teleflex LLC | $814.38 | 2020-2025 | Manta |
| Angiodynamics, INC. | $510.87 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $488.29 | 2019-2023 | Lifevest |
| Acist Medical Systems, INC. | $440.22 | 2024-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $351.75 | 2023-2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Spectrawave, INC | $228.80 | 2024-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Heartflow, INC. | $208.61 | 2020-2023 | Ffrct |
| Cordis US Corp. | $205.09 | 2025 | Selution Slr Ptca |
| Terumo Medical Corporation | $158.87 | 2021-2025 | Heartrail, Glidewire, Angio-Seal |
| Cvrx, INC. | $155.46 | 2021 | |
| Arrow International, INC. | $148.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $144.56 | 2020-2023 | Xarelto |
| Saranas, INC. | $142.86 | 2022 | |
| Siemens Medical Solutions USA, INC. | $142.66 | 2019 | |
| Endotronix, INC. | $134.50 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Biotronik INC. | $133.05 | 2025 | Biomonitor |
| Bolton Medical INC | $130.50 | 2019 | |
| Z-Medica, LLC | $129.19 | 2020 | |
| Novo Nordisk INC | $109.63 | 2022 | |
| Pfizer INC. | $87.30 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $86.08 | 2023 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $84.98 | 2023-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $54.02 | 2020-2024 | Andexxa |
| Kestra Medical Technology Services, INC. | $50.23 | 2023 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $18.03 | 2021 | |
| Argon Medical Devices, INC. | $13.33 | 2023 | Tips |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Mangla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.